A Novel Controlled Metabolic Accelerator for the Treatment of Obesity-Related Heart Failure with Preserved Ejection Fraction: Rationale and Design of the Phase 2a HuMAIN Trial is a research paper published in European Journal of Heart Failure (2024). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U01AG076928
National Institutes of Health
Grant: R01AG078153
National Institutes of Health
Grant: R01AG045551
National Institutes of Health
Grant: R01AG18915
National Institutes of Health
Grant: P30AG021332
National Institutes of Health
Grant: U24AG059624
National Institutes of Health
Grant: U01HL160272
National Institutes of Health
Grant: R01 HL 131029
National Institutes of Health
Grant: R01 HL 1511841
National Institutes of Health
Grant: R01 HL 159514
National Institutes of Health
Grant: U01 HL 160278
National Institutes of Health
Grant: R01 HL128526
National Institutes of Health
Grant: R01 HL162828
National Institutes of Health
Grant: U01 HL160226
National Institutes of Health
Grant: U54 HL160273
National Institutes of Health
Grant: R01 HL107577
National Institutes of Health
Grant: R01 HL127028
National Institutes of Health
Grant: R01 HL140731
National Institutes of Health
Grant: R01 HL149423
US Department of Defense
Grant: W81XWH2210245
NHLBI NIH HHS
Grant: R01 HL151841
NIA NIH HHS
Grant: R01 AG018915
Rivus Pharmaceuticals, Inc
FWCI
3.60
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords